05.10.25 -- Outsourced Pharma Best Of April

There are predictions of disruptions in the industry. The Trump tariff ploy will fail, and prices will skyrocket. But have you considered that the tariff tantrum will lower national export/import duties?

After our "Biotech Winter" – a period starting circa 2021 with tens of thousands of layoffs and stagnating investment — is it springtime for biotech? Chris Frew, CEO of BioBuzz Networks, says yes.

Why did George Hlass found Pharma Expanse, roughly described as a “BD-for-hire organization”? He says it was born of experiences over a long career in the role of business development professional.

Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.

Advancing a small molecule candidate from discovery to clinic is a complicated journey. Learn more about the factors that can accelerate timelines and help improve downstream clinical outcomes.

For complex projects involving oral solid dosage (OSD) and sterile drug products, selecting the ideal CDMO can play a pivotal role in determining the success of a drug candidate.